Federated Hermes’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-867
Closed -$1.53K 2293
2022
Q4
$1.53K Buy
867
+699
+416% +$1.86K ﹤0.01% 2028
2022
Q3
$1K Sell
168
-52,388
-100% -$322K ﹤0.01% 2102
2022
Q2
$291K Buy
+52,556
New +$430K ﹤0.01% 1473
2021
Q4
Sell
-1,072,617
Closed -$34.4M 2339
2021
Q3
$34.4M Hold
1,072,617
0.07% 355
2021
Q2
$44.6M Sell
1,072,617
-20,511
-2% -$843K 0.08% 302
2021
Q1
$55.5M Buy
1,093,128
+15
+0% +$785 0.11% 248
2020
Q4
$35.5M Sell
1,093,113
-121,749
-10% -$1.73M 0.07% 319
2020
Q3
$14.5M Hold
1,214,862
0.03% 481
2020
Q2
$16.1M Buy
1,214,862
+1,142,858
+1,587% +$14.9M 0.04% 435
2020
Q1
$810K Buy
+72,004
New +$884K ﹤0.01% 1234

Other funds holding DMTK

Federated Hermes's DMTK Position: Q1 2023 in Review

Federated Hermes sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2023, closing a stake of 867 shares — an estimated $1.53K sold.

Federated Hermes first reported a position in DMTK in Q1 2020 and held it in 10 quarters. The position peaked at $55.5M in Q1 2021. 99 funds tracked by Wall St. Rank hold DMTK as of Q1 2023.

  • Federated Hermes reported no remaining DermTech, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Federated Hermes sold 867 DermTech, Inc. Common Stock shares in Q1 2023, an estimated $1.53K.
  • Federated Hermes first reported a position in DermTech, Inc. Common Stock in Q1 2020 and held it in 10 quarters.
  • Federated Hermes's DermTech, Inc. Common Stock position peaked at $55.5M in Q1 2021.
  • 99 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2023.

Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.